Dr. Richard Lee

Dr. Richard Lee
Dr. Richard Lee, MD MBA, completed his surgical internship and urology residency at NewYork- Presbyterian/Weill Cornell Medical Center. He completed his fellowship in Female Pelvic Medicine and Reconstructive Surgery at both NYP-WC and Memorial Sloan Kettering Cancer Center, after which he was appointed to the full-time faculty at Weill Cornell in July 2011. He currently holds joint appointments within the Departments of Urology, Obstetrics & Gynecology, as well as Population Health Sciences and currently serves as Residency Program Director for the Urology department as well as the Academic Director for the Executive MBA/MS in Healthcare Leadership program. Dr. Lee maintains an active practice in both men and women. His expertise is in the treatment and evaluation of men and women with incontinence, pelvic organ prolapse, overactive bladder, and benign prostatic hyperplasia. Dr. Lee is an active participant in translational research and is currently involved in several research protocols as either primary or co-investigator that includes NIH, the Bill and Melinda Gates Foundation, other non-profit foundations, and industry support. He is active in global health efforts, helping to spearhead HIV risk reduction efforts in both China and Africa. He has also been listed as a New York Rising Star since 2014. Dr. Lee is an active peer reviewer for European Urology, Journal of Urology, British Journal of Urology International, and Advances in Urology. He has published over 150 peer-reviewed articles and co-authored chapters in several urologic textbooks.

Languages Spoken:

English,. Spanish, Chinese, Taiwanese

Medical School:

University of Pennsylvania

Residency:

New York Presbyterian Cornell

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only